BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1820275)

  • 1. The Genetic Activity Profile database.
    Waters MD; Stack HF; Garrett NE; Jackson MA
    Environ Health Perspect; 1991 Dec; 96():41-5. PubMed ID: 1820275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposed method for assembly and interpretation of short-term test data.
    Brusick D
    Environ Health Perspect; 1991 Dec; 96():101-11. PubMed ID: 1820250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic toxicology data in the evaluation of potential human environmental carcinogens.
    Waters MD; Stack HF; Jackson MA
    Mutat Res; 1999 Jul; 437(1):21-49. PubMed ID: 10425388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and impact of the Gene-Tox-Program, genetic activity profiles, and their computerized data bases.
    Waters MD
    Environ Mol Mutagen; 1994; 23 Suppl 24():67-72. PubMed ID: 8162911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Databases applicable to quantitative hazard/risk assessment--towards a predictive systems toxicology.
    Waters M; Jackson M
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):34-44. PubMed ID: 18675838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity.
    Tennant RW
    Environ Health Perspect; 1991 Dec; 96():47-51. PubMed ID: 1820276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of database construction and interrogation of relevance to the accurate prediction of rodent carcinogenicity and mutagenicity.
    Ashby J
    Environ Health Perspect; 1991 Dec; 96():97-100. PubMed ID: 1820286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity evaluations and ongoing studies: the IARC databases.
    Vainio H; Coleman M; Wilbourn J
    Environ Health Perspect; 1991 Dec; 96():5-9. PubMed ID: 1820277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to identifying specialized batteries of bioassays for specific classes of chemicals: class analysis using mutagenicity and carcinogenicity relationships and phylogenetic concordance and discordance patterns. 1. Composition and analysis of the overall data base. A report of phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Ray VA; Kier LD; Kannan KL; Haas RT; Auletta AE; Wassom JS; Nesnow S; Waters MD
    Mutat Res; 1987 May; 185(3):197-241. PubMed ID: 3574331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proportions of mutagens among chemicals in commerce.
    Zeiger E; Margolin BH
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):219-25. PubMed ID: 11067778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic activity profiles in the testing and evaluation of chemical mixtures.
    Waters MD; Claxton LD; Stack HF; Brady AL; Graedel TE
    Teratog Carcinog Mutagen; 1990; 10(2):147-64. PubMed ID: 1973853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the spectra of genetic activity produced by known or suspected human carcinogens.
    Garrett NE; Stack HF; Gross MR; Waters MD
    Mutat Res; 1984; 134(2-3):89-111. PubMed ID: 6504068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity databases.
    Klopman G; Rosenkranz H
    Environ Health Perspect; 1991 Dec; 96():67-75. PubMed ID: 1820281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic activity profiles--application in assessing potential carcinogenicity of complex environmental mixtures.
    Waters MD; Claxton LD; Stack HF; Graedel TE
    IARC Sci Publ; 1990; (104):75-88. PubMed ID: 2228145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the U.S. EPA's Office of Pesticide Programs' toxicity information databases.
    Dearfield KL; Quest JA; Whiting RJ; Stack HF; Waters MD
    Environ Health Perspect; 1991 Dec; 96():53-6. PubMed ID: 1820278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human exposures to mutagens--an analysis using the genetic activity profile database.
    Tice RR; Stack HF; Waters MD
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):585-9. PubMed ID: 8781387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between carcinogenicity and mutagenicity based on chemicals evaluated in the IARC monographs.
    Bartsch H; Tomatis L
    Environ Health Perspect; 1983 Jan; 47():305-17. PubMed ID: 6337827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.